Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/24/1991 | EP0424020A1 Oral compositions containing monoperoxy acids |
04/24/1991 | EP0423943A2 Use of collagenase inhibitors in the treatment of demyelinating diseases, in particular multiple sclerosis |
04/24/1991 | EP0423870A1 Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives |
04/24/1991 | EP0423842A2 Steroids and therapeutic compositions containing same |
04/24/1991 | EP0423805A2 Condensed purine derivatives |
04/24/1991 | EP0423802A1 Phenoxy-heterocyclic compounds |
04/24/1991 | EP0423777A2 Method of treating gastrointestinal motility disorders |
04/24/1991 | EP0423776A2 N-(6)-substituted adenosine compounds |
04/24/1991 | EP0423771A2 Use of L-sugars for the manufacture of laxative compositions |
04/24/1991 | EP0423748A1 Stabilized pharmaceutical composition and its production |
04/24/1991 | EP0423747A2 Glycosyl-etoposide prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates |
04/24/1991 | EP0423728A2 Esters of castanospermine in the treatment of cerebral malaria |
04/24/1991 | EP0423714A2 Hair revitalizing agent |
04/24/1991 | EP0423707A2 Platinum complexes |
04/24/1991 | EP0423697A2 Emulsion of lipid containing a prostaglandin analogue |
04/24/1991 | EP0423695A2 Aerosol composition for topical medicament |
04/24/1991 | EP0423618A1 Inosine/guanosine derivatives as immunosuppressive agents |
04/24/1991 | EP0423617A1 Inosine/Guanosine derivatives as antineoplastic agents |
04/24/1991 | EP0423524A2 Propiophenone derivatives and their preparation and pharmaceutical use |
04/24/1991 | EP0423445A1 13-alkyl-23-imino and 13-halo-23-imino derivatives of LL-F28249 compounds and their use as endo- and ectoparasiticidal insecticidal, acaricidal and nematocidal agents |
04/24/1991 | EP0423419A1 Inhibitive agent against activity of alpha-amylase |
04/24/1991 | EP0423366A1 Phospholipid derivatives |
04/24/1991 | EP0423325A1 Use of cobalt to enhance urinary copper excretion |
04/24/1991 | EP0423318A1 Therapeutic cholesterol gallstone dissolution method. |
04/24/1991 | EP0423221A1 Immunosuppressive agents. |
04/24/1991 | EP0423191A1 Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon |
04/24/1991 | EP0381742A4 Receptor mediated endocytosis type mri contrast agents |
04/24/1991 | CN1050880A Inosine/guanosine derivatives |
04/24/1991 | CN1050879A Novel alpha-glucosidase inhibitors |
04/24/1991 | CN1050875A Aroyl-urres |
04/24/1991 | CN1050874A Aromatic 2-aminoalkyi-1,2-benzoisothizol-3(2h)one-1, 1-dioxide dervatives |
04/24/1991 | CN1050872A Aromatic 2-aminoalkyl-1,2-bemzoisothiazol-3(2h)one-1, 1-dioxide derivatives |
04/24/1991 | CN1012434B Improvements in or relating to leukotriene antagonists |
04/24/1991 | CA2067491A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
04/24/1991 | CA2028256A1 Multiple layer transdermal drug administration system |
04/24/1991 | CA2028246A1 Tricyclic quinoline antineoplastic agents |
04/24/1991 | CA2028209A1 Quinolone compounds and a process for their preparation |
04/24/1991 | CA2028208A1 Quinolone compounds and a process for their preparation |
04/24/1991 | CA2028176A1 Carbapenem compounds |
04/24/1991 | CA2026642A1 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor |
04/24/1991 | CA2026602A1 Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor |
04/23/1991 | USRE33574 Substituted biphenyl derivatives |
04/23/1991 | US5010204 Glaucoma treatment |
04/23/1991 | US5010185 Processes for tigogenin beta-cellobioside |
04/23/1991 | US5010108 Treatment of gastrointestinal disorders |
04/23/1991 | US5010107 Dietary supplement of calcium glucarate to inhibit beta-glucoronidase and N-hydroxyphenyl retinamide to elevate cyclic AMP |
04/23/1991 | US5010097 Collagenase inhibitors, antiarthritic agents |
04/23/1991 | US5010096 Administering benzodioxino pyrrole compounds; adrenergic blocking agents |
04/23/1991 | US5010095 N-(W-substituted alkyl)-'-(imidazol-4-yl)alkyl)guanidine |
04/23/1991 | US5010093 Nitric ester derivative |
04/23/1991 | US5010092 Protection against chemically-induced kidney damage by methimazole |
04/23/1991 | US5010091 2,4-dihalogeno-6-pyridylethanolphenylisopropylamines for shifting the protein-fat ratio of animals in favor of protein |
04/23/1991 | US5010090 Anxiolytic, antiepilepic agents; muscular disorders |
04/23/1991 | US5010088 Inotropic agents |
04/23/1991 | US5010084 Antihistamines; asthma |
04/23/1991 | US5010081 6-thioxanthines |
04/23/1991 | US5010080 !anticarcinogenic agents |
04/23/1991 | US5010079 Indolone derivatives, their preparation and their application in therapy |
04/23/1991 | US5010076 1,7-fused 1H-indole-2-carboxylic acid-N-(1,4-benzodiazepin-3-yl)amides |
04/23/1991 | US5010074 Treating CNS disorders; dopamine antagonist; bioavailability |
04/23/1991 | US5010073 Use of liposomes as carriers for metalloporphyrins |
04/23/1991 | US5010072 Lactamimides as calcium antagonists |
04/23/1991 | US5010071 Topical antiandrogens |
04/23/1991 | US5010070 Side effect reduction |
04/23/1991 | US5010069 Stable liquid form of 5-aminosalicylic acid |
04/23/1991 | US5010065 Cyclodextrin clathrates of 5-cyanoprostacyclin derivatives and their use as pharmaceutical agents |
04/23/1991 | US5010064 Anticoagulants |
04/23/1991 | US5010063 Antithrombotic agent, anticoagulant, reduces hemorrhage |
04/23/1991 | US5010062 Therapeutic agent and method of inhibiting vascularization of tumors |
04/23/1991 | US5010061 Guar flour |
04/23/1991 | US5010060 Method of treating herpes simplex viral infection employing pyrimidine derivatives |
04/23/1991 | US5010059 Pharmaceutical products and lactosyl compounds |
04/23/1991 | US5010058 Antinflammatory agents, autoimmune diseases, lupus |
04/23/1991 | US5009895 Sustained release with high and low viscosity HPMC |
04/23/1991 | CA1283422C Hydroxyvitamin d _compounds and process for preparing same |
04/23/1991 | CA1283419C Substituted di-t-butylphenols |
04/23/1991 | CA1283418C Cardiotonic alkanoylthiazolones |
04/23/1991 | CA1283416C Carbamoyloxymethylalkylcarbapenem compounds |
04/23/1991 | CA1283409C2 Process and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers |
04/23/1991 | CA1283408C2 Processes and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their steroisomers |
04/23/1991 | CA1283405C Crystalline hydrate of oral cephalosporin and its composition |
04/23/1991 | CA1283361C Antiviral combinations |
04/23/1991 | CA1283360C Process for the preparation of a viscosity-stable antacid composition |
04/23/1991 | CA1283359C Compositions of neocarzinostatin derivative for non-injection administration |
04/23/1991 | CA1283357C Thrombosis treatment with fibrinolytics and prostacyclins |
04/22/1991 | CA2028042A1 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
04/21/1991 | WO1991005546A1 Solid tumor treatment method and composition |
04/21/1991 | WO1991005545A1 Liposome microreservoir composition and method |
04/21/1991 | WO1991005543A1 Pharmaceutical and cosmetic depigmentation compositions with a caffeic acid base |
04/21/1991 | CA2028086A1 Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
04/21/1991 | CA2028076A1 Synthesis of swainsonine and analogs thereof |
04/21/1991 | CA2027838A1 Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives |
04/21/1991 | CA2013562A1 Crystalline 2-0- -d-glucopyranosyl-l-ascorbic acid, and its preparation and uses |
04/20/1991 | WO1991006005A1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
04/20/1991 | CA2028002A1 Method of treating gastrointestinal motility disorders |
04/20/1991 | CA2027999A1 N-(6)-substituted adenosine compounds |
04/20/1991 | CA2027952A1 Topical medicinal pressurized aerosol compositions and method of preparation, method of use and article of manufacture thereof |
04/20/1991 | CA2027896A1 Antimuscarinic bronchodilators |
04/20/1991 | CA2027840A1 Tetracyclic pyrrole lactam derivatives |
04/20/1991 | CA2027839A1 Pyrimidines |